Related Experiment Video
Updated: May 19, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Acute promyelocytic leukemia with t(15;17): a case study
1Department of Medical Laboratory Science, Armstrong Atlantic State University, Savannah, GA, USA.
MLO: Medical Laboratory Observer
|August 3, 2012
Summary
Acute promyelocytic leukemia (APL) with the t(15;17) translocation involves abnormal promyelocyte proliferation, coagulopathy, and thrombocytopenia. Diagnosis and treatment are enabled by laboratory analysis and fusion gene testing.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML).
- APL is characterized by a specific chromosomal translocation, t(15;17).
- This translocation results in the formation of a fusion gene crucial for APL development.
Observation:
- Patients present with abnormal proliferation of promyelocytic cells in peripheral blood and bone marrow.
- Coagulopathy and thrombocytopenia are common clinical features.
- The presence of the t(15;17) translocation is a hallmark of this APL subtype.
Findings:
- Laboratory analysis can identify the characteristic promyelocytosis.
- Confirmatory testing for the PML-RARA fusion gene confirms the diagnosis.
- The t(15;17) translocation is a consistent finding in APL.
Implications:
- Accurate diagnosis of APL with t(15;17) is essential for appropriate treatment selection.
- Understanding the genetic basis aids in developing targeted therapies.
- Early detection through laboratory analysis improves patient outcomes in APL.
